Digital Medication Management in Polypharmacy —Findings of a Cluster-Randomized, Controlled Trial With a Stepped-Wedge Design in Primary Care Practices (AdAM)

CONCLUSION: The planned analyses did not reveal any significant effect of the intervention. Pandemic-adjusted analyses yielded evidence that the mortality of adult patients with polypharmacy might potentially be lowered by the CDSS. Controlled trials with appropriate follow-up are needed to prove that a CDSS has significant effects on mortality in patients with polypharmacy.PMID:38377330 | DOI:10.3238/arztebl.m2024.0007

Source: Deutsches Arzteblatt International - February 20, 2024 Category: General Medicine Authors: Robin Br ünn Jale Basten Dorothea Lemke Alexandra Piotrowski Sara S öling Bastian Surmann Wolfgang Greiner Daniel Grandt Petra Kellermann-M ühlhoff Sebastian Harder Paul Glasziou Rafael Perera Juliane K öberlein-Neu Peter Ihle Marjan van den Akker Nin Source Type: research